发布求助
文献互助 智能选刊 最新文献

Im Focus Onkologie最新文献

筛选
英文 中文
CDK4/6-Inhibition bei Brustkrebs
Im Focus Onkologie Pub Date : 2021-06-01 DOI: 10.1007/s15015-017-3457-x
Redaktion Facharztmagazine
{"title":"CDK4/6-Inhibition bei Brustkrebs","authors":"Redaktion Facharztmagazine","doi":"10.1007/s15015-017-3457-x","DOIUrl":"https://doi.org/10.1007/s15015-017-3457-x","url":null,"abstract":"","PeriodicalId":13382,"journal":{"name":"Im Focus Onkologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82073536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cetuximab plus FOLFOX erweist sich als effektive Kombination bei mCRC 是mCRC的有效组合
Im Focus Onkologie Pub Date : 2018-12-01 DOI: 10.1007/s15015-018-4362-7
J. Neumaier
{"title":"Cetuximab plus FOLFOX erweist sich als effektive Kombination bei mCRC","authors":"J. Neumaier","doi":"10.1007/s15015-018-4362-7","DOIUrl":"https://doi.org/10.1007/s15015-018-4362-7","url":null,"abstract":"","PeriodicalId":13382,"journal":{"name":"Im Focus Onkologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75475476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SCCHN: Induktionschemotherapie zusätzlich zur Cetuximab-Radiotherapie ohne Nutzen 相辅相成治疗相辅相成的治疗同时，bab的放射治疗起不了作用
Im Focus Onkologie Pub Date : 2018-12-01 DOI: 10.1007/s15015-018-4358-3
B. Kreutzkamp
{"title":"SCCHN: Induktionschemotherapie zusätzlich zur Cetuximab-Radiotherapie ohne Nutzen","authors":"B. Kreutzkamp","doi":"10.1007/s15015-018-4358-3","DOIUrl":"https://doi.org/10.1007/s15015-018-4358-3","url":null,"abstract":"","PeriodicalId":13382,"journal":{"name":"Im Focus Onkologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75534012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mammakarzinom: CDK4/6-Hemmung auch nach zwei Jahren vorteilhaft 即使经过两年，疾病控制中心还是可以忍受
Im Focus Onkologie Pub Date : 2018-12-01 DOI: 10.1007/s15015-018-4353-8
J. Neumaier
{"title":"Mammakarzinom: CDK4/6-Hemmung auch nach zwei Jahren vorteilhaft","authors":"J. Neumaier","doi":"10.1007/s15015-018-4353-8","DOIUrl":"https://doi.org/10.1007/s15015-018-4353-8","url":null,"abstract":"","PeriodicalId":13382,"journal":{"name":"Im Focus Onkologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85235070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erhöhen ACE-Hemmer das Lungenkrebsrisiko? 酵素抑制剂会增加患肺癌的风险?
Im Focus Onkologie Pub Date : 2018-12-01 DOI: 10.1007/s15015-018-4346-7
P. Risch
{"title":"Erhöhen ACE-Hemmer das Lungenkrebsrisiko?","authors":"P. Risch","doi":"10.1007/s15015-018-4346-7","DOIUrl":"https://doi.org/10.1007/s15015-018-4346-7","url":null,"abstract":"","PeriodicalId":13382,"journal":{"name":"Im Focus Onkologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86124865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mehr unabhängige Studien nach Zulassung von Onkologika nötig 肿瘤学认证需要更多的独立研究
Im Focus Onkologie Pub Date : 2018-12-01 DOI: 10.1007/s15015-018-4331-1
Springer Medizin
{"title":"Mehr unabhängige Studien nach Zulassung von Onkologika nötig","authors":"Springer Medizin","doi":"10.1007/s15015-018-4331-1","DOIUrl":"https://doi.org/10.1007/s15015-018-4331-1","url":null,"abstract":"","PeriodicalId":13382,"journal":{"name":"Im Focus Onkologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90768799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Febrile Neutropenie: neues Biosimilar
Im Focus Onkologie Pub Date : 2018-12-01 DOI: 10.1007/s15015-018-4390-3
Ine Schmale
{"title":"Febrile Neutropenie: neues Biosimilar","authors":"Ine Schmale","doi":"10.1007/s15015-018-4390-3","DOIUrl":"https://doi.org/10.1007/s15015-018-4390-3","url":null,"abstract":"","PeriodicalId":13382,"journal":{"name":"Im Focus Onkologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90829663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Service für Liquid Biopsy verfügbar 服务局<s:1> r液体活检verf<s:1> gbar
Im Focus Onkologie Pub Date : 2018-12-01 DOI: 10.1007/s15015-018-4392-1
Red.
{"title":"Service für Liquid Biopsy verfügbar","authors":"Red.","doi":"10.1007/s15015-018-4392-1","DOIUrl":"https://doi.org/10.1007/s15015-018-4392-1","url":null,"abstract":"","PeriodicalId":13382,"journal":{"name":"Im Focus Onkologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89528805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management venöser Thromboembolien bei Tumorpatienten 处理venöser血栓栓塞性肿瘤患者
Im Focus Onkologie Pub Date : 2018-12-01 DOI: 10.1007/s15015-018-4370-7
K. Kröger, F. Langer
{"title":"Management venöser Thromboembolien bei Tumorpatienten","authors":"K. Kröger, F. Langer","doi":"10.1007/s15015-018-4370-7","DOIUrl":"https://doi.org/10.1007/s15015-018-4370-7","url":null,"abstract":"","PeriodicalId":13382,"journal":{"name":"Im Focus Onkologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78514075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Leiden durch Biopsien vor Prostatektomie die Potenz und Kontinenz? 发育之前的插座是否导致了大便失禁
Im Focus Onkologie Pub Date : 2018-12-01 DOI: 10.1007/s15015-018-4375-2
C. Starostzik
{"title":"Leiden durch Biopsien vor Prostatektomie die Potenz und Kontinenz?","authors":"C. Starostzik","doi":"10.1007/s15015-018-4375-2","DOIUrl":"https://doi.org/10.1007/s15015-018-4375-2","url":null,"abstract":"","PeriodicalId":13382,"journal":{"name":"Im Focus Onkologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75199063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信